1.
Validation of a New Scoring System for Treatment Failure in CML Patients on Tyrosine Kinase Inhibitors in a real world setting . Mediterr J Hematol Infect Dis [Internet]. 2026 Jan. 1 [cited 2026 May 2];18(1):e2026013. Available from: https://www.mjhid.org/mjhid/article/view/6195